- Home
- BTCT vs XAIR Comparison
BTCT vs XAIR Comparison
Compare BTCT & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTCT | XAIR |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7M | 11.4M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | BTCT | XAIR |
|---|---|---|
| Price | $1.17 | $1.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 53.7K | ★ 318.1K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.09 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,705,000.00 |
| Revenue This Year | N/A | $126.42 |
| Revenue Next Year | $283.35 | $130.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 219.67 |
| 52 Week Low | $1.07 | $0.15 |
| 52 Week High | $5.50 | $3.78 |
Technical Indicators
Market Signals| Indicator | BTCT | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 40.35 | 42.64 |
| Support Level | $1.07 | $0.98 |
| Resistance Level | $1.84 | $1.25 |
| Average True Range (ATR) | 0.09 | 0.10 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 51.85 | 25.56 |
Price Performance
Historical ComparisonAbout BTCT BTC Digital Ltd.
BTC Digital Ltd is a crypto asset technology company based in the U.S. with a focus on bitcoin mining. The company also generates revenue through mining machine resale and rental business operations. Geographically, the financial assets of the company is located in the United States, Singapore, Hong Kong and the PRC.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.